Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
To show that Irbesartan improves endothelial dysfunction and the procoagulant state which are
thought to be the possible mechanisms, inducing a generalized vasculopathy associated with
microalbuminuria and vascular events in type II diabetic hypertensive patients